1. Cancer Biology

Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma

  1. Bo Gong  Is a corresponding author
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang  Is a corresponding author
  1. University of Electronic Science and Technology of China, China
  2. Chengdu University of Traditional Chinese Medicine, China
https://doi.org/10.7554/eLife.75340
Share this article
Cite this article
  1. Bo Gong
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang
(2022)
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma
eLife 11:e75340.
https://doi.org/10.7554/eLife.75340
  2. Download BibTeX
  3. Download .RIS

Abstract

Multiple myeloma (MM) accounts for ~10% of all haematologic malignancies. Little is known about high intratumour heterogeneities in patients stratified by the Revised International Staging System (R-ISS). Herein, we constructed a single-cell transcriptome atlas to compare differential expression patterns among stages. We found that a novel cytotoxic plasma cell (PC) population exhibited with NKG7 positive was obviously enriched in stage II patients. Additionally, a malignant plasma cell population with significantly elevated expression of MKI67 and PCNA was associated with unfavourable prognosis and Epstein-Barr virus (EBV) infection in our collected samples. Moreover, Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) was found and verified to promote proliferation of MM cell lines, suggesting RRM2 may serve as a detrimental marker in MM. The percentages of CD8+ T cells and NKT cells decreased along with R-ISS stages, reflecting the plasticity of the tumour immune microenvironment. Importantly, their crosstalks with myeloid cells and PC identified several potential immunotargets such as SIRPA-CD47, and CD74-MIF, respectively. Collectively, this study provided an R-ISS-related single-cell MM atlas and revealed the clinical significance of novel PC clusters, as well as potential immunotargets in MM progression.

Data availability

Sequencing data have been deposited in GEO under accession code GSE176131.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Bo Gong

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    For correspondence
    gongbo2007@hotmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2763-6829

  2. Ling Zhong

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Peng Hao

    Department of Orthopaedics, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Qian Zhang

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Tao Jiang

    Department of Hematology, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  6. Huan Li

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  7. Jialing Xiao

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  8. Chenglong Li

    Department of Hematology, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  9. Lan Luo

    Chengdu University of Traditional Chinese Medicine, Chengdu, China
    Competing interests
    The authors declare that no competing interests exist.

  10. Ping Shuai

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  11. Liang Wang

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  12. Yuping Liu

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  13. Yi Shi

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  14. Wei Zhang

    Department of Orthopaedics, University of Electronic Science and Technology of China, ChengDu, China
    For correspondence
    zhangwspine@163.com
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Natural Science Foundation of China (Youth Funds,82002212)

  • Ling Zhong

Science & Technology Department of Sichuan Province (Applied Basic Research,2022YFS0100)

  • Peng Hao

Chengdu Science and Technology Bureau (Applied Basic Research,2019-YF05-00572-SN)

  • Ling Zhong

China Postdoctoral Science Foundation (general program，2019M663567)

  • Ling Zhong

UESTC (Basic scientific research,ZYGX2020J024)

  • Ling Zhong

UESTC (Medicine-engineering interdisciplinary,ZYGX2021YGLH006)

  • Ling Zhong

Science &Technology Department of Sichuan Province (Outstanding Youth Fund，2022JDTD0024)

  • Bo Gong

Chengdu Science and Technology Bureau (Applied Basic Research,2022-YF05-01625-SN)

  • Bo Gong

Sichuan cadre health care project (Sichuan cadre health care project,2022-216)

  • Wei Zhang

UESTC (Medicine-engineering interdisciplinary,ZYGX2021YGLH204)

  • Wei Zhang

The roles of the funders were to do single cell sequence, analysis data, and verify the conclusions.

Ethics

Human subjects: Written informed consents were obtained from all subjects. All experimental procedures were approved by the Medical ethics committee of Sichuan Provincial People's Hospital and carried out in accordance with the principles of the Declaration of Helsinki. ALL of the patients signed the informed consent containing contact Information, the purpose of the study, risks and benefits from this study, consent to publish the manuscript. The protocol numbers was 2020-240.

Copyright

© 2022, Gong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,077
    views
  • 144
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bo Gong
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang
(2022)
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma
eLife 11:e75340.
https://doi.org/10.7554/eLife.75340

Share this article

https://doi.org/10.7554/eLife.75340

Categories and tags

Research organism

Further reading

    1. Cancer Biology
    2. Evolutionary Biology

    High-density sampling reveals volume growth in human tumours

    Arman Angaji, Michel Owusu ... Johannes Berg
    Research Article

    In growing cell populations such as tumours, mutations can serve as markers that allow tracking the past evolution from current samples. The genomic analyses of bulk samples and samples from multiple regions have shed light on the evolutionary forces acting on tumours. However, little is known empirically on the spatio-temporal dynamics of tumour evolution. Here, we leverage published data from resected hepatocellular carcinomas, each with several hundred samples taken in two and three dimensions. Using spatial metrics of evolution, we find that tumour cells grow predominantly uniformly within the tumour volume instead of at the surface. We determine how mutations and cells are dispersed throughout the tumour and how cell death contributes to the overall tumour growth. Our methods shed light on the early evolution of tumours in vivo and can be applied to high-resolution data in the emerging field of spatial biology.

    1. Cancer Biology
    2. Evolutionary Biology

    Cancers adapt to their mutational load by buffering protein misfolding stress

    Susanne Tilk, Judith Frydman ... Dmitri A Petrov
    Research Article

    In asexual populations that don’t undergo recombination, such as cancer, deleterious mutations are expected to accrue readily due to genome-wide linkage between mutations. Despite this mutational load of often thousands of deleterious mutations, many tumors thrive. How tumors survive the damaging consequences of this mutational load is not well understood. Here, we investigate the functional consequences of mutational load in 10,295 human tumors by quantifying their phenotypic response through changes in gene expression. Using a generalized linear mixed model (GLMM), we find that high mutational load tumors up-regulate proteostasis machinery related to the mitigation and prevention of protein misfolding. We replicate these expression responses in cancer cell lines and show that the viability in high mutational load cancer cells is strongly dependent on complexes that degrade and refold proteins. This indicates that the upregulation of proteostasis machinery is causally important for high mutational burden tumors and uncovers new therapeutic vulnerabilities.

    1. Cancer Biology
    2. Cell Biology

    Automated workflow for the cell cycle analysis of (non-)adherent cells using a machine learning approach

    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.